UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P.1.i.017 - Serotonin 2A receptor agonist binding with [11C]Cimbi-36 in the human brain is unaltered by citalopram/pindolol and acute tryptophan depletion

European neuropsychopharmacology, 2016-10, Vol.26, p.S307-S308

2016

Volltextzugriff (PDF)

Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain

NeuroImage (Orlando, Fla.), 2014-01, Vol.84, p.342-353

2014

Volltextzugriff (PDF)

PMH27 SUCCESSFULLY TREATED PATIENTS WITH VORTIOXETINE VERSUS VENLAFAXINE: A SIMPLIFIED COST-EFFECTIVENESS ANALYSIS IN ASIAN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

Value in health, 2019-11, Vol.22, p.S685-S685

2019

Volltextzugriff (PDF)

Characterization of [ 11 C]CIMBI-36 as a 5-HT 2A receptor agonist PET radioligand in the non-human primate brain

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, Vol.32, p.S64

2012

Volltextzugriff (PDF)

Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain

The international journal of neuropsychopharmacology, 2017-06, Vol.20 (9), p.683-691

2017

Volltextzugriff (PDF)

Pilot study on receptor binding and serotonin sensitivity of [ 11 C]CIMBI-36 in monkey brain

JOURNAL OF NUCLEAR MEDICINE, 2011, Vol.52

2011

Volltextzugriff (PDF)

The merits of context: Unfolding mental vulnerability as category and experience

Ethnography, 2022-12, Vol.23 (4), p.496-515

Ettrup Christiansen, Charlotte

2022

Volltextzugriff (PDF)

The prevalence of acromegaly is higher than previously reported: Changes over a three‐decade period

Clinical endocrinology (Oxford), 2022-12, Vol.97 (6), p.773-782

2022

Volltextzugriff (PDF)

Reach and uptake of Internet- and phone-based smoking cessation interventions: Results from a randomized controlled trial

Preventive medicine, 2014-05, Vol.62, p.38-43

2014

Volltextzugriff (PDF)

How does mHealth influence consulting practice between health professionals and individuals with low back pain? - A qualitative study from the perspective of health professionals

Disability and rehabilitation, 2024-09, Vol.46 (18), p.4129-4139

2024

Volltextzugriff (PDF)

Freedom of Religion but with Exceptions

Revue d'histoire du protestantisme, 2023-07, Vol.8 (2-3), p.317-334

Larsen, Kurt Ettrup

2023

Volltextzugriff (PDF)

The effectiveness of telephone counselling and internet- and text-message-based support for smoking cessation: results from a randomized controlled trial

Addiction (Abingdon, England), 2016-07, Vol.111 (7), p.1257-1266

2016

Volltextzugriff (PDF)

Blood BDNF concentrations reflect brain-tissue BDNF levels across species

The international journal of neuropsychopharmacology, 2011-04, Vol.14 (3), p.347-353

2011

Volltextzugriff (PDF)

Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine

Cephalalgia, 2022-09, Vol.42 (10), p.1005-1012

2022

Volltextzugriff (PDF)

Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2

Cephalalgia, 2022-07, Vol.42 (8), p.696-704

2022

Volltextzugriff (PDF)

Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab

BMC neurology, 2022-07, Vol.22 (1), p.1-251, Article 251

2022

Volltextzugriff (PDF)

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial

Lancet neurology, 2022-07, Vol.21 (7), p.597-607

2022

Volltextzugriff (PDF)

The TRH test provides valuable information in the diagnosis of central hypothyroidism in patients with known pituitary disease and low T4 levels

Frontiers in endocrinology (Lausanne), 2023-10, Vol.14, p.1226887-1226887

2023

Volltextzugriff (PDF)

Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-06, Vol.325 (23), p.2348

2021

Volltextzugriff (PDF)

Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies

Journal of headache and pain, 2021-11, Vol.22 (1), p.143-143, Article 143

2021

Volltextzugriff (PDF)

Looking for Collaborative Moments: Lessons from a Workshop on Mental Vulnerability and Photography

Collaborative anthropologies, 2021-04, Vol.13 (2), p.29-55

Christiansen, Charlotte Ettrup

2021

Volltextzugriff (PDF)

Eptinezumab for migraine prevention in patients 50 years or older

Acta neurologica Scandinavica, 2022-06, Vol.145 (6), p.698-705

2022

Volltextzugriff (PDF)

The Day We Were Dogs: Mental Vulnerability, Shared Reading, and Moments of Transformation

Ethos (Berkeley, Calif.), 2021-09, Vol.49 (3), p.286-307

2021

Volltextzugriff (PDF)

Preoperative Smoking Status and Postoperative Complications: A Systematic Review and Meta-analysis

Annals of surgery, 2014-01, Vol.259 (1), p.52-71

2014

Volltextzugriff (PDF)

Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study

Journal of headache and pain, 2022-02, Vol.23 (1), p.22-22, Article 22

2022

Volltextzugriff (PDF)

26 – 50 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(201)
Mit Volltextzugriff
(186)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P.1.i.017 - Serotonin 2A receptor agonist binding with [11C]Cimbi-36 in the human brain is unaltered by citalopram/pindolol and acute tryptophan depletion

Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain

PMH27 SUCCESSFULLY TREATED PATIENTS WITH VORTIOXETINE VERSUS VENLAFAXINE: A SIMPLIFIED COST-EFFECTIVENESS ANALYSIS IN ASIAN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

Characterization of [ 11 C]CIMBI-36 as a 5-HT 2A receptor agonist PET radioligand in the non-human primate brain

Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain

Pilot study on receptor binding and serotonin sensitivity of [ 11 C]CIMBI-36 in monkey brain

The merits of context: Unfolding mental vulnerability as category and experience

The prevalence of acromegaly is higher than previously reported: Changes over a three‐decade period

Reach and uptake of Internet- and phone-based smoking cessation interventions: Results from a randomized controlled trial

How does mHealth influence consulting practice between health professionals and individuals with low back pain? - A qualitative study from the perspective of health professionals

Freedom of Religion but with Exceptions

The effectiveness of telephone counselling and internet- and text-message-based support for smoking cessation: results from a randomized controlled trial

Blood BDNF concentrations reflect brain-tissue BDNF levels across species

Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine

Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2

Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial

The TRH test provides valuable information in the diagnosis of central hypothyroidism in patients with known pituitary disease and low T4 levels

Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial

Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies

Looking for Collaborative Moments: Lessons from a Workshop on Mental Vulnerability and Photography

Eptinezumab for migraine prevention in patients 50 years or older

The Day We Were Dogs: Mental Vulnerability, Shared Reading, and Moments of Transformation

Preoperative Smoking Status and Postoperative Complications: A Systematic Review and Meta-analysis

Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study

Suchergebnisse filtern